Publication

Article

BioPharm International

BioPharm International-10-15-2015
Volume2015 eBook
Issue 2

Cleaning Validation for Biologics

Author(s):

Can alternative approaches to the permitted/acceptable daily exposure be justified?

BioPharm International

eBooks Volume 28, Issue 14  

Many pharmaceutical companies have adopted the permitted daily exposure (PDE), or acceptable daily exposure (ADE), to set cleaning validation limits. Some regulatory agencies now require its use, but some companies continue to argue against it, particularly biologics manufacturers. Critics of the approach argue that protein molecules are denatured or degraded by their cleaning processes, and that alternate approaches should be used.   Read this article and other articles in

BioPharm International

's 2015

The Future of Bioprocessing

eBook.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
© 2025 MJH Life Sciences

All rights reserved.